Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit

Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit

Bibliographic Details
Main Authors:	Sebastian Jugl, Ruba Sajdeya, Earl J. Morris, Amie J. Goodin, Joshua D. Brown
Format:	Article
Language:	English
Published:	Karger Publishers 2021-06-01
Series:	Medical Cannabis and Cannabinoids
Subjects:	cannabidiol tetrahydrocannabinol cannabis entourage effect standardized unit dosing pharmacokinetic
Online Access:	https://www.karger.com/Article/FullText/517154

Similar Items

Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain
by: Sebastian Jugl, et al.
Published: (2023-04-01)

Assessing the bioactivity of cannabis extracts in larval zebrafish
by: Jessica Nixon, et al.
Published: (2021-10-01)

Cannabis Effects on Driving Performance: Clinical Considerations
by: Brianna Costales, et al.
Published: (2023-01-01)

Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry
by: Joshua D. Brown, et al.
Published: (2020-04-01)

Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
by: Adi Gabarin, et al.
Published: (2023-11-01)

An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry
by: Simon Erridge, et al.
Published: (2023-12-01)

Will Cannabis or Cannabinoids Protect You from SARS-CoV-2 Infection or Treat COVID-19?
by: Joshua D. Brown, et al.
Published: (2022-02-01)

Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars
by: Jacob Miguel Vigil, et al.
Published: (2023-02-01)

Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry
by: Claire Wang, et al.
Published: (2023-07-01)

A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
by: Matthew Murphy, et al.
Published: (2024-03-01)

Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population
by: Santiago Gómez Velásquez, et al.
Published: (2023-03-01)

Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey
by: Susan Mohamed, et al.
Published: (2022-03-01)

Priority areas for cannabis and cannabinoid product research in South Africa
by: Tanya N. Augustine, et al.
Published: (2018-06-01)

A Proteomic View of Cellular and Molecular Effects of Cannabis
by: Morteza Abyadeh, et al.
Published: (2021-09-01)

Understanding feeling “high” and its role in medical cannabis patient outcomes
by: Sarah S. Stith, et al.
Published: (2023-05-01)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
by: Swapnali Chetia, et al.
Published: (2020-08-01)

Propagation of Cannabis for Clinical Research: An Approach Towards a Modern Herbal Medicinal Products Development
by: Suman Chandra, et al.
Published: (2020-06-01)

The Anti-Inflammatory Effects of <i>Cannabis sativa</i> Extracts on LPS-Induced Cytokines Release in Human Macrophages
by: Mariia Zaiachuk, et al.
Published: (2023-06-01)

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
by: Erin L. Martin, et al.
Published: (2021-09-01)

Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
by: Lauren Eadie, et al.
Published: (2021-03-01)

Metabolomic Fingerprint of Behavioral Changes in Response to Full-Spectrum Cannabis Extracts
by: Zaid H. Maayah, et al.
Published: (2022-01-01)

Applications of <i>Cannabis Sativa</i> L. in Food and Its Therapeutic Potential: From a Prohibited Drug to a Nutritional Supplement
by: Amna Iftikhar, et al.
Published: (2021-12-01)

Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes
by: Hollis C. Karoly, et al.
Published: (2020-12-01)

The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder
by: Guldar Sayed Mohammad, et al.
Published: (2022-08-01)

Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
by: Sarah D. Pennypacker, et al.
Published: (2022-06-01)

UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder
by: Pim Ittiphakorn, et al.
Published: (2023-12-01)

Cannabis and Autoimmunity: Possible Mechanisms of Action
by: Giorgi V, et al.
Published: (2021-07-01)

Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer
by: Sapna Oberoi, et al.
Published: (2022-09-01)

Optimal condition of cannabis maceration to obtain the high cannabidiol and Δ9-tetrahydrocannabinol content
by: CHAOWALIT MONTON, et al.
Published: (2019-10-01)

Perinatal Cannabis Exposures and Autism Spectrum Disorders
by: Ruba Sajdeya, et al.
Published: (2021-05-01)

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
by: Arun Bhaskar, et al.
Published: (2021-07-01)

A review of studies evaluating medical cannabis for the chronic pain management
by: Justyna Żyga
Published: (2022-08-01)

The use of medical cannabis in pediatric palliative care: a case series
by: Antuan Divisic, et al.
Published: (2021-11-01)

Potential impacts of soil microbiota manipulation on secondary metabolites production in cannabis
by: Bulbul Ahmed, et al.
Published: (2021-07-01)

Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
by: Kennadi Johnson, et al.
Published: (2024-04-01)

Online survey of medicinal cannabis users: Qualitative analysis of patient-level data
by: Albert Garcia-Romeu, et al.
Published: (2022-09-01)

α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabis sativa
by: Wiwit Suttithumsatid, et al.
Published: (2022-01-01)

In planta Female Flower Agroinfiltration Alters the Cannabinoid Composition in Industrial Hemp (Cannabis sativa L.)
by: Michihito Deguchi, et al.
Published: (2022-07-01)

A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics
by: Kevin P. Hill, et al.
Published: (2021-07-01)

Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know
by: Alecsandra Gorzo, et al.
Published: (2022-08-01)